Literature DB >> 22560078

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Jichao Qin1, Xin Liu, Brian Laffin, Xin Chen, Grace Choy, Collene R Jeter, Tammy Calhoun-Davis, Hangwen Li, Ganesh S Palapattu, Shen Pang, Kevin Lin, Jiaoti Huang, Ivan Ivanov, Wei Li, Mahipal V Suraneni, Dean G Tang.   

Abstract

Prostate cancer (PCa) is heterogeneous and contains both differentiated and undifferentiated tumor cells, but the relative functional contribution of these two cell populations remains unclear. Here we report distinct molecular, cellular, and tumor-propagating properties of PCa cells that express high (PSA(+)) and low (PSA(-/lo)) levels of the differentiation marker PSA. PSA(-/lo) PCa cells are quiescent and refractory to stresses including androgen deprivation, exhibit high clonogenic potential, and possess long-term tumor-propagating capacity. They preferentially express stem cell genes and can undergo asymmetric cell division to generate PSA(+) cells. Importantly, PSA(-/lo) PCa cells can initiate robust tumor development and resist androgen ablation in castrated hosts, and they harbor highly tumorigenic castration-resistant PCa cells that can be prospectively enriched using ALDH(+)CD44(+)α2β1(+) phenotype. In contrast, PSA(+) PCa cells possess more limited tumor-propagating capacity, undergo symmetric division, and are sensitive to castration. Altogether, our study suggests that PSA(-/lo) cells may represent a critical source of castration-resistant PCa cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560078      PMCID: PMC3348510          DOI: 10.1016/j.stem.2012.03.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  41 in total

1.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Imaging hematopoietic precursor division in real time.

Authors:  Mingfu Wu; Hyog Young Kwon; Frederique Rattis; Jordan Blum; Chen Zhao; Rina Ashkenazi; Trachette L Jackson; Nicholas Gaiano; Tim Oliver; Tannishtha Reya
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

3.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Authors:  Sooryanarayana Varambally; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico A Monzon; Michael J Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

Review 4.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

5.  Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

Authors:  K A Klein; R E Reiter; J Redula; H Moradi; X L Zhu; A R Brothman; D J Lamb; M Marcelli; A Belldegrun; O N Witte; C L Sawyers
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

6.  Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression.

Authors:  Charles J Ryan; Alex Smith; Priti Lal; Jaya Satagopan; Victor Reuter; Peter Scardino; William Gerald; Howard I Scher
Journal:  Urology       Date:  2006-10       Impact factor: 2.649

7.  Distant metastases from prostatic carcinoma express androgen receptor protein.

Authors:  A Hobisch; Z Culig; C Radmayr; G Bartsch; H Klocker; A Hittmair
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

8.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

9.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

10.  Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

Authors:  J A Ruizeveld de Winter; P J Janssen; H M Sleddens; M C Verleun-Mooijman; J Trapman; A O Brinkmann; A B Santerse; F H Schröder; T H van der Kwast
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more
  162 in total

1.  Prostate cancer stem cells: molecular characterization for targeted therapy.

Authors:  Asfar S Azmi; Fazlul H Sarkar
Journal:  Asian J Androl       Date:  2012-06-25       Impact factor: 3.285

Review 2.  Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.

Authors:  Andrea K Miyahira; Joshua M Lang; Robert B Den; Isla P Garraway; Tamara L Lotan; Ashley E Ross; Tanya Stoyanova; Steve Y Cho; Jonathan W Simons; Kenneth J Pienta; Howard R Soule
Journal:  Prostate       Date:  2015-10-19       Impact factor: 4.104

3.  Isolation of cancer stem cells from human prostate cancer samples.

Authors:  Samuel J Vidal; S Aidan Quinn; Janis de la Iglesia-Vicente; Dennis M Bonal; Veronica Rodriguez-Bravo; Adolfo Firpo-Betancourt; Carlos Cordon-Cardo; Josep Domingo-Domenech
Journal:  J Vis Exp       Date:  2014-03-14       Impact factor: 1.355

Review 4.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 5.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

6.  Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Authors:  Yanru Wang; Jennifer A Freedman; Hongliang Liu; Patricia G Moorman; Terry Hyslop; Daniel J George; Norman H Lee; Steven R Patierno; Qingyi Wei
Journal:  Int J Cancer       Date:  2017-06-01       Impact factor: 7.396

7.  Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.

Authors:  Tanya Stoyanova; Aaron R Cooper; Justin M Drake; Xian Liu; Andrew J Armstrong; Kenneth J Pienta; Hong Zhang; Donald B Kohn; Jiaoti Huang; Owen N Witte; Andrew S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 8.  Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Authors:  Dingxiao Zhang; Dean G Tang; Kiera Rycaj
Journal:  Semin Cancer Biol       Date:  2018-05-09       Impact factor: 15.707

9.  Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Authors:  Jennifer A Freedman; Yanru Wang; Xuechan Li; Hongliang Liu; Patricia G Moorman; Daniel J George; Norman H Lee; Terry Hyslop; Qingyi Wei; Steven R Patierno
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

Review 10.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.